NCT05934435

Brief Summary

This study will investigate effects of a psychoeducation pain management skills intervention on adults with persistent pain by training a cohort of American Society for Pain Management Nursing (ASPMN) nurses to deliver and it \[Empowered Relief (ER)\], as a single-session video-conferenced program. The primary objective is to evaluate the effects of ASPMN nurse-provided ER versus waitlist control (WLC) on pain catastrophizing, pain bothersomeness, pain intensity, pain interference, sleep disturbance, physical function, depression, anxiety, and social isolation for patients with persistent pain. Secondarily, feasibility and acceptability of the ER program will be assessed through recruitment and retention data and qualitative satisfaction data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
149

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

July 7, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2024

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 13, 2024

Completed
Last Updated

April 10, 2025

Status Verified

January 1, 2025

Enrollment Period

12 months

First QC Date

June 17, 2023

Last Update Submit

April 7, 2025

Conditions

Keywords

Pain

Outcome Measures

Primary Outcomes (1)

  • Change in Pain Catastrophizing

    Measured by self-report

    Participants will be assessed at baseline, and then at 2, 4, and 8 week timepoints for change over time.

Secondary Outcomes (1)

  • Change in Pain Intensity

    Participants will be assessed at baseline, and then at 2, 4, and 8 week timepoints for change over time.

Study Arms (2)

Empowered Relief treatment

EXPERIMENTAL

Participants randomized to the ER group will complete a HIPAA compliant, password protected 2-hour Zoom ER class delivered by an ER-trained ASPMN nurse.

Other: Empowered Relief

Wait-list Control

OTHER

Participants randomized to the Wait-list Control group will continue their usual pain care for 2 months and complete surveys to compare with the experimental treatment group. After serving as controls, they will be invited to attend the 2-hour Zoom ER class delivered by an ER-trained ASPMN nurse.

Other: Empowered Relief

Interventions

psycho-educational pain skills training

Also known as: ER
Empowered Relief treatmentWait-list Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age \> 18 years
  • pain \>3 months more than half the time
  • English fluency
  • ability to attend a one-time web-based class and complete web-based surveys.

You may not qualify if:

  • Previous participation in ER class
  • cognitive impairment
  • non-English speaking
  • psychological factors that would preclude comprehension of material or full participation in the study as determined by the investigators.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington State University

Spokane, Washington, 99201, United States

Location

MeSH Terms

Conditions

Chronic PainPain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Marian Wilson, PhD

    Washington State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Biostatistician will be blinded to ER treatment group or Wait-list Control group.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: After randomized 1:1 to one of two unblinded study groups: ER and Wait-List Control, participants randomized to the ER group will complete the ER class. A crossover intervention class will be offered to those patient participants randomized to WLC once the ER group has completed their class and follow up assessments, estimated at 2 months post intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 17, 2023

First Posted

July 7, 2023

Study Start

November 1, 2023

Primary Completion

October 25, 2024

Study Completion

November 13, 2024

Last Updated

April 10, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

Can be requested from principal investigator

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
After publication
Access Criteria
Use for secondary analysis

Locations